Syngeneic Models to Support Bispecific T Cell Engager Drug Development
Time: 9:00 am
day: Day 1 AM
Details:
- Model development to recapitulate the target expression and the tumor microenvironment
- Uncovering strategies for combination treatments
- Understanding mechanisms of treatment resistance
